Islets transplanted in immunoisolation devices: A review of the progress and the challenges that remain

Endocrine Reviews

Volumn 32, Issue 6, 2011, Pages 827-844

  O'Sullivan, Esther S ^a   Vegas, Arturo ^b   Anderson, Daniel G ^b   Weir, Gordon C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; ALGINIC ACID; ANION; BIOMATERIAL; CALCINEURIN INHIBITOR; CHITOSAN; COLLAGEN; COPOLYMER; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; ETANERCEPT; EVEROLIMUS; HYDROXYMETHYLPOLYSULFONE; INFLIXIMAB; INSULIN; MACROGOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; OXYGEN; POLY(DIALLYLDIMETHYLAMMONIUM CHLORIDE); POLYCATION; POLYETHYLENEIMINE; POLYLYSINE; POLYMER; POLYORNITHINE; RAPAMYCIN; SILICON DIOXIDE; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ANGIOGENESIS; BIOCOMPATIBILITY; CARDIOVASCULAR DISEASE; CELL AGGREGATION; CLINICAL TRIAL (TOPIC); DEVICE; DRUG MEGADOSE; EMBRYONIC STEM CELL; GRAFT REJECTION; HUMAN; HYPOXEMIA; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IMMUNOISOLATION DEVICE; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LOW DRUG DOSE; NANOENCAPSULATION; NEPHROTOXICITY; NONHUMAN; OMENTUM; OXYGEN DIFFUSION; OXYGEN TRANSPORT; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; TISSUE NECROSIS; TREATMENT FAILURE; VASCULARIZATION; XENOGRAFT;

ANIMALS; BIOMIMETIC MATERIALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROTOPIC;

EID: 83755225863     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2010-0026     Document Type: Review

References (150)

1. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV 2000 Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238
2. Tharavanij T, Betancourt A, Messinger S, Cure P, Leitao CB, Baidal DA, Froud T, Ricordi C, Alejandro R 2008 Improved long-term health-related quality of life after islet transplantation. Transplantation 86:1161-1167
3. Kahn SE, Zraika S, Utzschneider KM, Hull RL 2009 The β-cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia 52:1003-1012
4. Scharp D, Lacy P, Ricordi C, Boyle P, Santiago J, Cryer P, Gingerick R, Jaffe A, Anderson C, Flye W 1989 Human islet transplantation in patients with type I diabetes. Transplant Proc 21:2744-2745
5. Ryan EA, PatyBW,Senior PA, Bigam D, Alfadhli E, KnetemanNM, Lakey JR, Shapiro AM 2005 Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069
6. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR 2006 International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355:1318-1330
7. Frank A, Deng S, Huang X, Velidedeoglu E, Bae YS, Liu C, Abt P, Stephenson R, Mohiuddin M, Thambipillai T, Markmann E, Palanjian M, Sellers M, Naji A, Barker CF, Markmann JF 2004 Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann Surg 240:631-640; discussion 640-643
8. Ritz-Laser B, Oberholzer J, Toso C, Brulhart MC, Zakrzewska K, Ris F, Bucher P, Morel P, Philippe J 2002 Molecular detection of circulating β-cells after islet transplantation. Diabetes 51:557-561
9. Davalli AM, Ogawa Y, Ricordi C, Scharp DW, Bonner-Weir S, Weir GC 1995 A selective decrease in the β-cell mass of human islets transplanted into diabetic nude mice. Transplantation 59:817-820
10. Blondet JJ, Carlson AM, Kobayashi T, Jie T, Bellin M, Hering BJ, Freeman ML, Beilman GJ, Sutherland DE 2007 The role of total pancreatectomy and islet autotransplantation for chronic pancreatitis. Surg Clin North Am 87: 1477-1501, x
11. Alejandro R, Barton FB, Hering BJ, Wease S 2008 Update from the Collaborative Islet Transplant Registry. Transplantation 86:1783-1788
12. Bonner-Weir S, Weir GC 2005 New sources of pancreatic β-cells. Nat Biotechnol 23:857-861
13. D'AmourKA,BangAG,Eliazer S, KellyOG,AgulnickAD, Smart NG, Moorman MA, Kroon E, Carpenter MK, Baetge EE 2006 Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 24:1392-1401
14. Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, Young H, Richardson M, Smart NG, Cunningham J, Agulnick AD, D'Amour KA, Carpenter MK, Baetge EE 2008 Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26:443-452
15. Matveyenko AV, Veldhuis JD, Butler PC 2008 Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and β-cell mass to age-related insulin resistance in rats. Am J Physiol Endocrinol Metab 295:E832-E841
16. Van Assche FA, Aerts L, De Prins F 1978 A morphological study of the endocrine pancreas in human pregnancy. Br J Obstet Gynaecol 85:818-820
17. Sorenson RL, Brelje TC 1997 Adaptation of islets of Langerhans to pregnancy: β-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 29:301-307
18. de Koning EJ, Bodkin NL, Hansen BC, Clark A 1993 Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction inβ-cell population. Diabetologia 36:378-384
19. Butler AE, Cao-Minh L, Galasso R, Rizza RA, Corradin A, Cobelli C, Butler PC 2010 Adaptive changes in pancreatic β-cell fractional area and β-cell turnover in human pregnancy. Diabetologia 53:2167-2176
20. Chen S, Borowiak M, Fox JL, Maehr R, Osafune K, Davidow L, Lam K, Peng LF, Schreiber SL, Rubin LL, Melton D 2009 A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat Chem Biol 5:258-265
21. Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song KH, Sharma A, O'Neil JJ 2000 In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 97:7999-8004
22. Aviv V, Meivar-Levy I, Rachmut IH, Rubinek T, Mor E, Ferber S 2009 Exendin-4 promotes liver cell proliferation and enhances the PDX-1-induced liver to pancreas transdifferentiation process. J Biol Chem 284:33509-33520
23. NagayaM,Katsuta H, Kaneto H, Bonner-Weir S, Weir GC 2009 Adult mouse intrahepatic biliary epithelial cells induced in vitro to become insulin-producing cells. J Endocrinol 201:37-47
24. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA 2008 In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature 455:627-632
25. d'Apice AJ, Cowan PJ 2008 Gene-modified pigs. Xenotransplantation 15:87-90
26. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, Beard C, Brambrink T, Wu LC, Townes TM, Jaenisch R 2007 Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318:1920-1923
27. Takahashi K, Yamanaka S 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676
28. Tateishi K, He J, Taranova O, Liang G, D'Alessio AC, Zhang Y 2008 Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem 283: 31601-31607
29. Halban PA, German MS, Kahn SE, Weir GC 2010 Current status of islet cell replacement and regeneration therapy. J Clin Endocrinol Metab 95:1034-1043
30. van der Windt DJ, Bottino R, Casu A, Campanile N, Cooper DK 2007 Rapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies. Xenotransplantation 14:288-297
31. Harlan DM, Kenyon NS, Korsgren O, Roep BO 2009 Current advances and travails in islet transplantation. Diabetes 58:2175-2184
32. Bellin MD, Sutherland DE, Beilman GJ, Hong-McAtee I, Balamurugan AN, Hering BJ, Moran A 2011 Similar islet function in islet allotransplant and autotransplant recipients, despite lower islet mass in autotransplants. Transplantation 91:367-372
33. Biarnés M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E 2002 β-Cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 51:66-72
34. Montaña E, Bonner-Weir S, Weir GC 1993 β-Cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice. J Clin Invest 91:780-787
35. Potter KJ, Abedini A, Marek P, Klimek AM, Butterworth S, Driscoll M, Baker R, Nilsson MR, Warnock GL, Oberholzer J, Bertera S, Trucco M, Korbutt GS, Fraser PE, Raleigh DP, Verchere CB 2010 Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci USA 107:4305-4310
36. Jaeger C, Brendel MD, Hering BJ, Eckhard M, Bretzel RG 1997 Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Diabetes 46:1907-1910
37. Hilbrands R, Huurman VA, Gillard P, Velthuis JH, De Waele M, Mathieu C, Kaufman L, Pipeleers-Marichal M, Ling Z, Movahedi B, Jacobs-Tulleneers-Thevissen D, Monbaliu D, Ysebaert D, Gorus FK, Roep BO, Pipeleers DG, Keymeulen B 2009 Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients. Diabetes 58:2267-2276
38. Toso C, McCall M, Emamaullee J, Merani S, Davis J, Edgar R, Pawlick R, Kin T, Knudsen LB, Shapiro M 2010 Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture. Transpl Int 23:259-265
39. Mineo D, Sageshima J, Burke GW, Ricordi C 2009 Minimization and withdrawal of steroids in pancreas and islet transplantation. Transpl Int 22:20-37
40. Zhang N, Su D,QuS, Tse T, Bottino R, Balamurugan AN, Xu J, Bromberg JS, Dong HH 2006 Sirolimus is associated with reduced islet engraftment and impaired β-cell function. Diabetes 55:2429-2436
41. Zahr E, Molano RD, Pileggi A, Ichii H, Jose SS, Bocca N, An W, Gonzalez-Quintana J, Fraker C, Ricordi C, Inverardi L 2007 Rapamycin impairs in vivo proliferation of islet β-cells. Transplantation 84:1576-1583
42. Nir T, Melton DA, Dor Y 2007 Recovery from diabetes in mice by β-cell regeneration. J Clin Invest 117:2553-2561
43. Gao R, Ustinov J, Korsgren O, Otonkoski T 2007 Effects of immunosuppressive drugs on in vitro neogenesis of human islets: mycophenolate mofetil inhibits the proliferation of ductal cells. Am J Transplant 7:1021-1026
44. Fraenkel M, Ketzinel-Gilad M, Ariav Y, Pappo O, Karaca M, Castel J, Berthault MF, Magnan C, Cerasi E, Kaiser N, Leibowitz G 2008 mTOR inhibition by rapamycin prevents β-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes. Diabetes 57:945-957
45. Lakey JR, Kin T, Warnock GL, Shapiro AM, Tsapogas P, Imes S, Korbutt GS, Kneteman NM, Rajotte RV, Ryan EA 2007 Long-term graft function after allogeneic islet transplantation. Cell Transplant 16:441-446
46. Hering BJ, Kandaswamy R, Ansite JD, Eckman PM, Nakano M, Sawada T, Matsumoto I, Ihm SH, Zhang HJ, Parkey J, Hunter DW, Sutherland DE 2005 Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 293:830-835
47. Froud T, Ricordi C, Baidal DA, Hafiz MM, Ponte G, Cure P, Pileggi A, Poggioli R, Ichii H, Khan A, Ferreira JV, Pugliese A, Esquenazi VV, Kenyon NS, Alejandro R 2005 Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 5:2037-2046
48. Bellin MD, Kandaswamy R, Parkey J, Zhang HJ, Liu B, Ihm SH, Ansite JD, Witson J, Bansal-Pakala P, Balamurugan AN, Papas KK, Papas K, Sutherland DE, Moran A, Hering BJ 2008 Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant 8:2463-2470
49. Fiorina P, Shapiro AM, Ricordi C, Secchi A 2008 The clin-ical impact of islet transplantation. Am J Transplant 8:1990-1997
50. Lynch RJ, Platt JL 2009 Escaping from rejection. Transplantation 88:1233-1236
51. Daneman D 2002 Islet cell transplantation and other new technologies for treating type 1 diabetes: a paediatric view. Horm Res 57(Suppl 1): 54-59
52. Hathout E, Lakey J, Shapiro J 2003 Islet transplant: an option for childhood diabetes? Arch Dis Child 88:591-594
53. Chang TM 1964 Semipermeable microcapsules. Science 146:524-525
54. Browning H, Resnik P 1951 Homologous and heterologous transplantation of pancreatic tissue in normal and diabetic mice. Yale J Biol Med 24:140-152
55. House EL, Burton C, Cooper H, Anderson E 1958 The implantation of neonatal pancreas into the cheek pouch of the alloxan diabetic hamster. Endocrinology 63:389-391
56. Ferguson J, Scothorne RJ, Johnston ID 1973 Proceedings: the survival of transplanted isolated pancreatic islets in the omentum and testis. Br J Surg 60:907
57. Chick WL, Perna JJ, Lauris V, Low D, Galletti PM, Panol G, Whittemore AD, Like AA, Colton CK, Lysaght MJ 1977 Artificial pancreas using living β-cells: effects on glucose homeostasis in diabetic rats. Science 197:780-682
58. Lim F, Sun AM 1980 Microencapsulated islets as bioartificial endocrine pancreas. Science 210:908-910
59. Lacy PE, Hegre OD, Gerasimidi-Vazeou A, Gentile FT, Dionne KE 1991 Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 254:1782-1784
60. Colton CK 1995 Implantable biohybrid artificial organs. Cell Transplant 4:415-436
61. Martinsen A, Skjåk-Braek G, Smidsrød O 1989 Alginate as immobilization material. I. Correlation between chemical and physical properties of alginate gel beads. Biotechnol Bioeng 33:79-89
62. De Vos P, De Haan BJ, Wolters GH, Strubbe JH, Van Schilfgaarde R 1997 Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia 40:262- 270
63. de Vos P, Bucko M, Gemeiner P, Navrátil M, Svitel J, Faas M, Strand BL, Skjak-Braek G, Morch YA, Vikartovská A, Lacík I, Kolláriková G, Orive G, Poncelet D, Pedraz JL, Ansorge-Schumacher MB 2009 Multiscale requirements for bioencapsulation in medicine and biotechnology. Biomaterials 30:2559-2570
64. 2+ on alginate microbeads. Biomacromolecules 7:1471-1480
65. Omer A, Duvivier-Kali V, Fernandes J, Tchipashvili V, Colton CK, Weir GC 2005 Long-term normoglycemia in rats receiving transplants with encapsulated islets. Transplantation 79:52-58
66. Safley SA, Cui H, Cauffiel S, Tucker-Burden C, Weber CJ 2008 Biocompatibility and immune acceptance of adult porcine islets transplanted intraperitoneally in diabetic NODmice in calcium alginate poly-L-lysine microcapsules versus barium alginate microcapsules without poly-Llysine. J Diabetes Sci Technol 2:760-767
67. Duvivier-Kali VF, Omer A, Parent RJ, O'Neil JJ, Weir GC 2001 Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 50:1698-1705
68. Strand BL, Ryan TL, In't Veld P, Kulseng B, Rokstad AM, Skjak-Brek G, Espevik T 2001 Poly-L-lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant 10:263-275
69. de Vos P, de Haan BJ, Kamps JA, Faas MM, Kitano T 2007 ζ-Potentials of alginate-PLL capsules: a predictive measure for biocompatibility? J Biomed Mater Res A 80:813-819
70. Calafiore R, Basta G, Luca G, Boselli C, Bufalari A, Bufalari A, Cassarani MP, Giustozzi GM, Brunetti P 1999 Transplantation of pancreatic islets contained in minimal volume microcapsules in diabetic high mammalians. Ann NY Acad Sci 875:219-232
71. Calafiore R, Basta G, Luca G, Lemmi A, Racanicchi L, Mancuso F, Montanucci MP, Brunetti P 2006 Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. Transplant Proc 38:1156-1157
72. Loudovaris T, Jacobs S, Young S, Maryanov D, Brauker J, Johnson RC 1999 Correction of diabetic nod mice with insulinomas implanted within Baxter immunoisolation devices. J Mol Med 77:219-222
73. Wang T, Adcock J, Kühtreiber W, Qiang D, Salleng KJ, Trenary I, Williams P 2008 Successful allotransplantation of encapsulated islets in pancreatectomized canines for diabetic management without the use of immunosuppression. Transplantation 85:331-337
74. Wang T, Lacík I, Brissová M, Anilkumar AV, Prokop A, Hunkeler D, Green R, Shahrokhi K, Powers AC 1997 An encapsulation system for the immunoisolation of pancreatic islets. Nat Biotechnol 15:358-362
75. Renken A, Hunkeler D 2007 Polyvinylamine-based capsules: a mechanistic study of the formation using alginate and cellulose sulphate. J Microencapsul 24:323-336
76. Schneider S, Feilen PJ, Slotty V, Kampfner D, Preuss S, Berger S, Beyer J, Pommersheim R 2001 Multilayer capsules: a promising microencapsulation system for transplantation of pancreatic islets. Biomaterials 22:1961-1970
77. Wong H, Chang TM 1991 A novel two step procedure for immobilizing living cells in microcapsules for improving xenograft survival. Biomater Artif Cells Immobilization Biotechnol 19:687-697
78. Iwata H, Kobayashi K, Takagi T, Oka T, Yang H, Amemiya H, Tsuji T, Ito F 1994 Feasibility of agarose microbeads with xenogeneic islets as a bioartificial pancreas. J Biomed Mater Res 28:1003-1011
79. Gazda LS, Vinerean HV, Laramore MA, Diehl CH, Hall RD, Rubin AL, Smith BH 2007 Encapsulation of porcine islets permits extended culture time and insulin independence in spontaneously diabetic BB rats. Cell Transplant 16:609-620
80. Iwata H, Takagi T, Kobayashi K, Oka T, Tsuji T, Ito F 1994 Strategy for developing microbeads applicable to islet xenotransplantation into a spontaneous diabetic NOD mouse. J Biomed Mater Res 28:1201-1207
81. Kin T, Iwata H, Aomatsu Y, Ohyama T, Kanehiro H, Hisanaga M, Nakajima Y 2002 Xenotransplantation of pig islets in diabetic dogs with use of a microcapsule composed of agarose and polystyrene sulfonic acid mixed gel. Pancreas 25:94-100
82. 2SO. Cryobiology 60: 159-164
83. Shen F, Li AA, Cornelius RM, Cirone P, Childs RF, Brash JL, Chang PL 2005 Biological properties of photocrosslinked alginate microcapsules. J Biomed Mater Res B Appl Biomater 75:425-434
84. Cruise GM, Scharp DS, Hubbell JA 1998 Characterization of permeability and network structure of interfacially photopolymerized poly(ethylene glycol) diacrylate hydrogels. Biomaterials 19:1287-1294
85. Lin CC, Anseth KS 2009 Glucagon-like peptide-1 functionalizedPEGhydrogels promote survival and function of encapsulated pancreatic β-cells. Biomacromolecules 10: 2460-2467
86. Lee DY, Nam JH, Byun Y 2004 Effect of polyethylene glycol grafted onto islet capsules on prevention of splenocyte and cytokine attacks. J Biomater Sci Polym Ed 15: 753-766
87. Hill RS, CruiseGM,Hager SR, Lamberti FV,YuX, Garufis CL, Yu Y, Mundwiler KE, Cole JF, Hubbell JA, Hegre OD, Scharp DW 1997 Immunoisolation of adult porcine islets for the treatment of diabetes mellitus. The use of photopolymerizable polyethylene glycol in the conformal coating of mass-isolated porcine islets. Ann NY Acad Sci 831: 332-343
88. Krol S, del Guerra S, Grupillo M, Diaspro A, Gliozzi A, Marchetti P 2006 Multilayer nanoencapsulation. New approach for immune protection of human pancreatic islets. Nano Lett 6:1933-1939
89. Wilson JT, Cui W, Chaikof EL 2008 Layer-by-layer assembly of a conformal nanothin PEG coating for intraportal islet transplantation. Nano Lett 8:1940-1948
90. Kizilel S, Scavone A, Liu X, Nothias JM, Ostrega D, Witkowski P, Millis M 2010 Encapsulation of pancreatic islets within nano-thin functional polyethylene glycol coatings for enhanced insulin secretion. Tissue Eng PartA16:2217- 2228
91. Teramura Y, Kaneda Y, Iwata H 2007 Islet-encapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. Biomaterials 28:4818-4825
92. Teramura Y, Iwata H 2009 Islet encapsulation with living cells for improvement of biocompatibility. Biomaterials 30:2270-2275
93. Teramura Y, Minh LN, Kawamoto T, Iwata H 2010 Microencapsulation of islets with living cells using PolyDNAPEG-lipid conjugate. Bioconjug Chem 21:792-796
94. Khor E, Lim LY 2003 Implantable applications of chitin and chitosan. Biomaterials 24:2339-2349
95. Yang KC, Qi Z, Wu CC, Shirouza Y, Lin FH, Yanai G, Sumi S 2010 The cytoprotection of chitosan based hydrogels in xenogeneic islet transplantation: an in vivo study in streptozotocin-induced diabetic mouse. Biochem Biophys Res Commun 393:818-823
96. Zhao F, Yin Y, Lu WW, Leong JC, Zhang W, Zhang J, Zhang M, Yao K 2002 Preparation and histological evaluation of biomimetic three-dimensional hydroxyapatite/chitosan-gelatin network composite scaffolds. Biomaterials 23:3227-3234
97. Chung TW, Yang J, Akaike T, Cho KY, Nah JW, Kim SI, Cho CS 2002 Preparation of alginate/galactosylated chitosan scaffold for hepatocyte attachment. Biomaterials 23: 2827-2834
98. Dufour JM, Rajotte RV, Zimmerman M, Rezania A, Kin T, Dixon DE, Korbutt GS 2005 Development of an ectopic site for islet transplantation, using biodegradable scaffolds. Tissue Eng 11:1323-1331
99. Hiscox AM, Stone AL, Limesand S, Hoying JB, Williams SK 2008 An islet-stabilizing implant constructed using a preformed vasculature. Tissue Eng Part A 14:433-440
100. Dautzenberg H, Schuldt U, Grasnick G, Karle P, Müller P, LöhrM, Pelegrin M, Piechaczyk M, Rombs KV,Günzburg WH,Salmons B, Saller RM 1999 Development of cellulose sulfate-based polyelectrolyte complex microcapsules for medical applications. Ann NY Acad Sci 875:46-63
101. LöhrM, Hoffmeyer A, Kröger J, Freund M, Hain J, Holle A, Karle P, Knöfel WT, Liebe S,Müller P, Nizze H, Renner M, Saller RM, Wagner T, Hauenstein K, Günzburg WH, Salmons B 2001 Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. Lancet 357: 1591-1592
102. Stadlbauer V, Stiegler PB, Schaffellner S, Hauser O, Halwachs G, Iberer F, Tscheliessnigg KH, Lackner C 2006 Morphological and functional characterization of a pancreatic β-cell line microencapsulated in sodium cellulose sulfate/poly(diallyldimethylammonium chloride). Xenotransplantation 13:337-344
103. Boninsegna S, Bosetti P, Carturan G, Dellagiacoma G, Dal Monte R, Rossi M 2003 Encapsulation of individual pancreatic islets by sol-gel SiO2: a novel procedure for perspective cellular grafts. J Biotechnol 100:277-286
104. Kim YY, Chae SY, Kim S, Byun Y, Bae YH 2005 Improved phenotype of rat islets in a macrocapsule by co-encapsulation with cross-linked Hb. J Biomater Sci Polym Ed 16: 1521-1535
105. Isayeva IS, Kasibhatla BT, Rosenthal KS, Kennedy JP 2003 Characterization and performance of membranes designed for macroencapsulation/implantation of pancreatic islet cells. Biomaterials 24:3483-3491
106. Suzuki K, Bonner-Weir S, Hollister-Lock J, Colton CK, Weir GC 1998 Number and volume of islets transplanted in immunobarrier devices. Cell Transplant 7:47-52
107. Check E 2002 Diabetes trial stirs debate on safety of xenotransplants. Nature 419:5
108. Juang JH, Bonner-Weir S, Ogawa Y, Vacanti JP, Weir GC 1996 Outcome of subcutaneous islet transplantation improved by polymer device. Transplantation 61:1557-1561
109. Pileggi A, Molano RD, Ricordi C, Zahr E, Collins J, Valdes R, Inverardi L 2006 Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 81:1318-1324
110. Suzuki K, Bonner-Weir S, Trivedi N, Yoon KH, Hollister-Lock J, Colton CK, Weir GC 1998 Function and survival of macroencapsulated syngeneic islets transplanted into streptozocin-diabetic mice. Transplantation 66:21-28
111. Trivedi N, Steil GM, Colton CK, Bonner-Weir S, Weir GC 2000 Improved vascularization of planar membrane diffusion devices following continuous infusion of vascular endothelial growth factor. Cell Transplant 9:115-124
112. Lee SH, Hao E, Savinov AY, Geron I, Strongin AY, Itkin-Ansari P 2009 Human β-cell precursors mature into functional insulin-producing cells in an immunoisolation device: implications for diabetes cell therapies. Transplantation 87:983-991
113. Lembert N, Wesche J, Petersen P, Doser M, Zschocke P, Becker HD, Ammon HP 2005 Encapsulation of islets in rough surface, hydroxymethylated polysulfone capillaries stimulates VEGF release and promotes vascularization after transplantation. Cell Transplant 14:97-108
114. Nilsson B, Korsgren O, Lambris JD, Ekdahl KN 2010 Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition? Trends Immunol 31: 32-38
115. Dang TT, Xu Q, Bratlie KM, O'Sullivan ES, Chen XY, Langer R, Anderson DG 2009 Microfabrication of homogenous, asymmetric cell-laden hydrogel capsules. Biomaterials 30:6896-6902
116. McKenzie IF, Xing PX, Vaughan HA, Prenzoska J, Dabkowski PL, Sandrin MS 1994 Distribution of the major xenoantigen (gal (α1-3)gal) for pig to human xenografts. Transpl Immunol 2:81-86
117. Omer A, Duvivier-Kali VF, Trivedi N, Wilmot K, Bonner-Weir S, Weir GC 2003 Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice. Diabetes 52:69-75
118. Duvivier-Kali VF, Omer A, Lopez-Avalos MD, O'Neil JJ, Weir GC 2004 Survival of microencapsulated adult pig islets in mice in spite of an antibody response. Am J Transplant 4:1991-2000
119. Soon-Shiong P, Feldman E, Nelson R, Heintz R, Yao Q, Yao Z, Zheng T, Merideth N, Skjak-Braek G, Espevik T 1993 Long-term reversal of diabetes by the injection of immunoprotected islets. Proc Natl Acad SciUSA90:5843- 5847
120. Soon-Shiong P, Heintz RE, Merideth N, Yao QX, Yao Z, Zheng T, Murphy M, Moloney MK, Schmehl M, Harris M 1994 Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343:950-951
121. Sun Y, Ma X, Zhou D, Vacek I, Sun AM 1996 Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 98:1417-1422
122. Elliott RB, Escobar L, Tan PL, Garkavenko O, Calafiore R, Basta P, VasconcellosAV,Emerich DF, Thanos C, Bambra C 2005 Intraperitoneal alginate-encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates. Transplant Proc 37:3505-3508
123. Maki T, Otsu I, O'Neil JJ, Dunleavy K, Mullon CJ, Solomon BA, Monaco AP 1996 Treatment of diabetes by xenogeneic islets without immunosuppression. Use of a vascularized bioartificial pancreas. Diabetes 45:342-347
124. Monaco AP, Maki T, Ozato H, Carretta M, Sullivan SJ, Borland KM, Mahoney MD, Chick WL, Muller TE, Wolfrum J 1991 Transplantation of islet allografts and xenografts in totally pancreatectomized diabetic dogs using the hybrid artificial pancreas. Ann Surg 214:339-360; discussion 361-362
125. Scharp DW, Swanson CJ, Olack BJ, Latta PP, Hegre OD, Doherty EJ, Gentile FT, Flavin KS, Ansara MF, Lacy PE 1994 Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes 43:1167-1170
126. Ghofaili KA, Fung M, Ao Z, Meloche M, Shapiro RJ, Warnock GL, Elahi D, Meneilly GS, Thompson DM 2007 Effect of exenatide on β-cell function after islet transplantation in type 1 diabetes. Transplantation 83:24-28
127. Calafiore R, Basta G, Luca G, Lemmi A, Montanucci MP, Calabrese G, Racanicchi L, Mancuso F, Brunetti P 2006 Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care 29:137-138
128. Tuch BE, Keogh GW, Williams LJ, Wu W, Foster JL, Vaithilingam V, Philips R 2009 Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care 32:1887-1889
129. Elliott RB, Escobar L, Tan PL, Muzina M, Zwain S, Buchanan C 2007 Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation. Xenotransplantation 14:157-161
130. Dufrane D, Goebbels RM, Saliez A, Guiot Y, Gianello P 2006 Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept. Transplantation 81:1345-1353
131. Kin T, Korbutt GS, Rajotte RV 2003 Survival and metabolic function of syngeneic rat islet grafts transplanted in the omental pouch. Am J Transplant 3:281-285
132. Berman DM, O'Neil JJ, Coffey LC, Chaffanjon PC, KenyonNM, Ruiz P Jr, Pileggi A, Ricordi C, Kenyon NS 2009 Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold. Am J Transplant 9:91-104
133. Christoffersson G, Henriksnäs J, Johansson L, Rolny C, AhlströmH, Caballero-Corbalan J, Segersvärd R, Permert J, Korsgren O, Carlsson PO, Phillipson M 2010 Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets. Diabetes 59:2569-2578
134. De Vos P, Vegter D, De Haan BJ, Strubbe JH, Bruggink JE, Van Schilfgaarde R 1996 Kinetics of intraperitoneally infused insulin in rats. Functional implications for the bioartificial pancreas. Diabetes 45:1102-1107
135. Omer A, Duvivier-Kali VF, Aschenbach W, Tchipashvili V, Goodyear LJ, Weir GC 2004 Exercise induces hypoglycemia in rats with islet transplantation. Diabetes 53:360- 365
136. Medarova Z, Evgenov NV, Dai G, Bonner-Weir S, Moore A 2006 In vivo multimodal imaging of transplanted pancreatic islets. Nat Protoc 1:429-435
137. Lewis AS 2008 Eliminating oxygen supply limitations for transplanted microencapsulated islets in the treatment of type 1 diabetes. Massachusetts Institute of Technology: Cambridge. p 233
138. Dionne KE 1990 Effect of hypoxia on insulin secretion and viability of pancreatic islet tissue. In: Chemical engineering. Cambridge, MA: Massachusetts Institute of Technology
139. O'Sullivan ES, Johnson AS, Omer A, Hollister-Lock J, Bonner-Weir S, Colton CK, Weir GC 2010 Rat islet cell aggregates are superior to islets for transplantation in microcapsules. Diabetologia 53:937-945
140. Chertow BS, Baranetsky NG, Sivitz WI, Meda P, Webb MD, Shih JC 1983 Cellular mechanisms of insulin release. Effects of retinoids on rat islet cell-to-cell adhesion, reaggregation, and insulin release. Diabetes 32:568-574
141. Bosco D, Orci L, Meda P 1989 Homologous but not heterologous contact increases the insulin secretion of individual pancreatic B-cells. Exp Cell Res 184:72-80
142. Pipeleers DG, Schuit FC, Van Schravendijk CF, Van de Winkel M 1985 Interplay of nutrients and hormones in the regulatin of glucagon release. Endocrinology 117:817-823
143. Halban PA, Powers SL, George KL, Bonner-Weir S 1987 Spontaneous reassociation of dispersed adult rat pancreatic islet cells into aggregates with three-dimensional architecture typical of native islets. Diabetes 36:783-790
144. King AJ, Fernandes JR, Hollister-Lock J, Nienaber CE, Bonner-Weir S, Weir GC 2007 Normal relationship of β-and non-β-cells not needed for successful islet transplantation. Diabetes 56:2312-2318
145. Bonner-Weir S, Orci L 1982 New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 31:883-889
146. Stagner JI, Samols E, Bonner-Weir S 1988 β-α-δ pancreatic islet cellular perfusion in dogs. Diabetes 37:1715-1721
147. Rickels MR, Schutta MH, Mueller R, Markmann JF, Barker CF, Naji A, Teff KL 2005 Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes. Diabetes 54:3205-3211
148. Su J, Hu BH, Lowe WL Jr, Kaufman DB, Messersmith PB 2010 Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation. Biomaterials 31: 308-314
149. KimS,WanKim S, Bae YH 2005 Synthesis, bioactivity and specificity of glucagon-like peptide-1 (7-37)/polymer conjugate to isolated rat islets. Biomaterials 26:3597-3606
150. King A, Lock J, Xu G, Bonner-Weir S, Weir GC 2005 Islet transplantation outcomes in mice are better with fresh islets and exendin-4 treatment. Diabetologia 48:2074-2079